11th International Conference on Tularemia

Co-Chairs

Amy Rasley, PhD, Deputy Group Leader, Microbiology/ Immunology, Lawrence Livermore National Laboratory, Livermore, USA
Amy Rasley, PhD
Staff Scientist, Translational Immunology, Lawrence Livermore National Laboratory, Livermore, USA
Staff Scientist, Lawrence Livermore National Laboratory, Livermore, USA
Nick Fischer, PhD
Staff Scientist, Lawrence Livermore National Laboratory, Livermore, USA

Tularemia 2026, scheduled for 27-30 September at the Portofino Hotel & Marina in Redondo Beach, California, will focus on fundamental, clinical, and applied research regarding any aspect of Francisella tularensis. Research uncovers not only the biology of this fascinating bacterium, but also provides the basis for future development of treatments, preventive interventions, and disease diagnosis.

Latest News

11th International Conference on Tularemia
Meetings / News

Save the Dates: Tularemia 2026

Online Abstract Submission Form Abstract Submission Deadline: 11 May 2026 00Days 00Hours 00Minutes 00Seconds Tularemia 2026, scheduled for 27-30 September at the Portofino Hotel & Marina in Redondo Beach, California, will focus …

Virtual Platform Registration Available

Browse the Program from Tularemia 2023


The Tularemia International Society wishes to acknowledge our sponsors for their financial support making Tularemia 2023 possible as well as very successful!

Funding for this conference is made possible, in part, by the Food and Drug Administration. This event is not a FDA sponsored event. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does any mention of trade names, commercial practices, or organization imply endorsement by the United States Government. 

This award is subject to the programmatic Terms and Conditions as specified in the Funding Opportunity Announcement: PAR 19-306 entitled FDA Scientific Conference Grant Program (R13). 

About

Tularemia is a rapidly progressive and potentially fatal zoonosis of humans caused by the intracellular bacterial pathogen, Francisella tularensis. Because of its low infectious dose and lethality when inhaled, F. tularensis was developed as a bioweapon by three countries, and remains a potential bioterroist agent. Research and understanding of tularemia pathogenesis, diagnosis, treatment, and prevention have been significantly advanced by the International Conferences on Tularemia, the first of which was held in Umea, Sweden in 1995. Attendance and impact of this triennial series of meetings has grown steadily in subsequent years. At present, this conference is a unique venue that brings together scientists and interested parties from the U.S., Canada, Scandinavia, Europe, Russia, and Japan.